Headquartered in Saint Louis, MO Fiscal year ends September NASDAQ: DOX amdocs.com
Amdocs Limited (NASDAQ: DOX) provides software products and services to communications and media companies worldwide. The company embeds intelligence into business, IT, and network operations, delivering measurable outcomes in customer experience, network performance, cloud modernization, and revenue growth. Amdocs serves the world's largest telecom operators through managed services engagements (approximately 67% of revenue), software licensing, systems integration, and digital transformation projects. With over 40 years of experience, the company processes billions of transactions daily across mission-critical systems globally. Amdocs is pursuing an agentic AI-driven strategy through its aOS (Agentic Telco Operating System) platform, designed to fundamentally transform how telco customers operate their businesses. The company is also expanding into new verticals beyond telecommunications and incubating emerging growth opportunities driven by the GenAI revolution. Amdocs reported revenue of $4.53 billion in fiscal 2025. Updated
Not every dividend survives a rough macro quarter, but some payouts are structured to keep growing no matter what the economy does. Five Nasdaq stocks built on contracted fees, recurring subscriptions, and…
A 66-year-old with $1.3 million can’t afford a dividend cut. The hunt for yield often pushes retirees into mega-caps, but I think the real income value sits in mid-caps whose GAAP earnings…
Amdocs (NASDAQ: DOX | DOX Price Prediction) and CSG Systems (NASDAQ: CSGS) both serve the telecom software market, but their recent earnings show two companies executing very different playbooks. Amdocs posted Q4…
Wednesday's top analyst upgrades and downgrades included Amgen, Canadian Pacific Kansas City, Carvana, Coinbase Global, Etsy, First Horizon, GE Healthcare Technologies, Gilead Sciences, Home Depot, Mosaic, Royal Caribbean Cruises, Vornado Realty Trust,…
Thursday's top analyst upgrades and downgrades included Affirm, Coinbase Global, Dominion Energy, GoodRx, Kroger, Nasdaq, Plug Power, PubMatic, Tyson Foods and Walt Disney.
Friday's top analyst upgrades and downgrades included AppLovin, BioCryst Pharmaceuticals, Boeing, CF Industries, Coupa Software, Crocs, Dutch Bros, DigitalOcean, Gilead Sciences, IBM, International Game Technology, Rivian Automotive, Roblox, VICI Properties and Visa,…
Altria, Amdocs, Grupo Televisa, and Quotient Technology all posted new 52-week lows on Wednesday.
Monday’s top analyst upgrades, downgrades and initiations include AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical and Unilever.
Thursday's top analyst calls include Boeing, eBay, Facebook, Incyte, Kinder Morgan, PayPal, Qualcomm and U.S. Steel.
Thursday's top analyst upgrades, downgrades and initiations include AMAG Pharmaceuticals, Devon Energy, eBay, Freshpet, Range Resources, Raytheon, SeaWorld and Zynga.
A new RBC report cites the strong growth potential, very reasonable valuations and the potential for strong free cash flow generation as three good reasons to look at mobile and cloud networking…
After RBC's firm's Mobile & Cloud investors day, the firm raised price targets on three top stocks it has rated Outperform.
The demand is huge for data, streaming video and audio, you name it. A new research report from RBC points to some of the top companies in the firm's coverage universe.
If Salesforce.com is acquired, there is every reason to think that these five companies could also get a strong look.
Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades and initiations seen from select Wall St. research calls. Amazon.com Inc. (NASDAQ: AMZN) cut to Neutral from Overweight at J.P. Morgan.…
Amdocs Limited (NASDAQ: DOX) provides software products and services to communications and media companies worldwide. The company embeds intelligence into business, IT, and network operations, delivering measurable outcomes in customer experience, network performance, cloud modernization, and revenue growth.
24/7 Wall St.'s 12-month price target for DOX is $76.55, rated Buy. The Wall Street consensus target is $79.25. DOX price prediction →
